Blogs

Be the first person to recommend this.
June 2018 Download the full issue in PDF format here .  June 2018: A Message from the President As researchers and clinicians, our work is rooted in the public good. We get out of bed every single day not only to help patients but to literally save their lives. Our work is incredibly important for our patients because it can lead to them continuing to live an abundant, long life. June 2018: Policy Perspective We all have mental associations with summer — school being out, trips “up north” (as we like to say here in Wisconsin), ice cream, the sound of the lawn mower and so much more. My summer days center around early morning rows ...
0 comments
Be the first person to recommend this.
This article appeared in the June 2018 issue of ASBMT eNews. Download the full issue  in PDF format here . By Mikaela VanMoorleghem, Education and Training Coordinator, Foundation for the Accreditation of Cellualar Therapy FACT Awards First Accreditation Under the New FACT Standards for Immune Effector Cells FACT awarded accreditation for immune effector cellular therapy under the new FACT Standards for Immune Effector Cells to The University of Texas MD Anderson CARTOX Program, directed by Elizabeth Shpall, M.D., and Sattva S. Neelapu, M.D. This is the first accreditation FACT has awarded to an immune effector cellular therapy program that is independent ...
0 comments
Be the first person to recommend this.
This article appeared in the June 2018 issue of ASBMT eNews. Download the full issue  in PDF format here . By Stephanie Farnia We all have mental associations with summer — school being out, trips “up north” (as we like to say here in Wisconsin), ice cream, the sound of the lawn mower and so much more. My summer days center around early morning rows on Lake Mendota in Madison, Wisconsin, evening neighborhood chats after a long winter of not seeing each other and, unusually, hours crafting responses to the CMS proposed rules. Summer is rule season in the regulatory world — IPPS, OPPS, PFS, QPP (if you ever find yourself in a bizarre game of Federal Agency ...
0 comments
Be the first person to recommend this.
In this month's Pharmacy SIG literature update: What is the role/value added of HCT-Pharmacists? Can you stop tacrolimus at day +60 after haplo transplants? Does palifermin help reduce mucositis with TBI-based allogeneic transplants? Plus, improving mortality in AL Amyloidosis, long-term outcomes and tandem transplants for Hodgkin lymphoma, and more! _ Literature summaries are provided as information only. Please refer to the original published articles for complete details on study methodology, results and discussion. *** = Must read. Landmark publication that affects practice ** = Recommend reading. Secondary paper that adds to literature ...
0 comments
Be the first person to recommend this.
This article appeared in the June 2018 issue of ASBMT eNews. Download the full issue  in PDF format here . On behalf of the ASBMT Committee on Education, we are pleased to continue our monthly self-directed learning quiz "Basic Principles and Practices of Hematopoietic Cell Transplantation and Cell Therapy – Question and Answer Approach” for fellows in training, highlighting HCT and cell therapy topics. Answers to each question appear with evidence-based “non-exhaustive peer-review commentary. Our aim is to provide you with a credible and freely available educational resource. Questions were generated and reviewed by Syed Abutalib, M.D., Mark R. Litzow, ...
0 comments
Be the first person to recommend this.
This article appeared in the June 2018 issue of ASBMT eNews. Download the full issue  in PDF format here . The American Society for Blood and Marrow Transplantation (ASBMT) in collaboration with The Sarah Cannon Blood Cancer Network and National Marrow Donor Program / Be The Match® is proud to announce the 5th Annual ASBMT Fall Clinical Education Conference. The conference will be held September 20-22, 2018 at the Omni Hotel in Nashville, Tenn. This multi-day conference for NPs, PAs, nurses, fellows and junior faculty will be focused on the care of blood and marrow transplant and cell therapy patients. The three-day conference will be packed with education ...
0 comments
Be the first person to recommend this.
This article appeared in the June 2018 issue of ASBMT eNews. Download the full issue  in PDF format here . Mollie Corbett, Manager of Operations Mollie Corbett has the pulse on everything at ASBMT. As the manager of operations, she executes the day-to-day functions and tasks for the association, always keeping an eye on the strategic plan and ensuring ASBMT meets its primary goals each year and for the next five years. She has extensive experience in healthcare association management and is excited to be a part of the ASBMT team. You will likely see her at ASBMT events and meetings as she is the person that everyone else comes to with questions. If ...
0 comments
Be the first person to recommend this.
This article appeared in the June 2018 issue of ASBMT eNews. Download the full issue  in PDF format here . Starting in June, ASBMT will begin to distribute The Cellular Scoop. This bimonthly digest, delivered straight to your inbox will be the best source for the latest information on upcoming events (for both ASBMT and partner organizations), member benefits and timely industry news. The digest will have easy-to navigate sections that point you to new and noteworthy information about ASBMT, things you may have missed and an upcoming calendar of events. Look out for the first issue later this mont
0 comments
Be the first person to recommend this.
This article appeared in the June 2018 issue of ASBMT eNews. Download the full issue  in PDF format here . ASBMT is excited to announce that we are accepting applications for the ASBMT Pharmacy SIG New Investigator Research Award. Interested applicants are required to submit a Letter of Intent (LOI). The LOI should follow the format below and will serve to permit assessment of eligibility for the award. Letters of Intent must be received by e-mail to the administrator of the grant, no later than Friday, June 29, 2018 (5:00 pm CST). For full instructions, please click her
0 comments
Be the first person to recommend this.
This article appeared in the June 2018 issue of ASBMT eNews. Download the full issue  in PDF format here . As the deadline for commentary on the new CMS recommendations nears, ASBMT will host a Town Hall on Thursday, June 14 from 11-12 p.m. CST. During the meeting, ASBMT will offer guidance, answer questions and provide feedback and insight on the proposed recommendations. Please see ASBMT’s statement on the recommendations here , which were presented at a hearing on May 16. ASBMT members can sign up for the Town Hall here. Please note that the Town Hall is open to ASBMT members only and a login is required to registe
0 comments
Be the first person to recommend this.
This article appeared in the June 2018 issue of ASBMT eNews. Download the full issue  in PDF format here . As researchers and clinicians, our work is rooted in the public good. We get out of bed every single day not only to help patients but to literally save their lives. Our work is incredibly important for our patients because it can lead to them continuing to live an abundant, long life. Being a part of this public-facing sector also means that we have regulations to consider in our work. These are important not only for properly regulating our field but also ensuring public and patient safety. As new policies and regulations are introduced in our ...
0 comments
Be the first person to recommend this.
This article appeared in the June 2018 issue of ASBMT eNews. Download the full issue  in PDF format here Study Looks at Skin GVHD Impact and Treatment Graft-versus-host disease (GVHD) targets Lgr5+ hair follicle stem cells (HFSCs), and topical ruxolitinib protects skin stem cells and maintains skin homeostasis in GVHD, reports a study appearing in Blood. Using mice, researchers discovered that GVHD reduced Lgr5+ HFSCs in association with impaired hair regeneration and skin wound healing after transplantation. Topical corticosteroids damaged HFSCs and failed to improve skin homeostasis, but ruxolitinib improved skin GVHD, protected Lgr5+ HFSCs and restored ...
0 comments
Be the first person to recommend this.
This article appeared in the June 2018 issue of ASBMT eNews. Download the full issue in PDF format here . Male Unrelated Donors Increase Risk of GVHD in Study Recipients of male unrelated donors have a higher risk of developing graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT) than recipients of parous female sibling donors, reports a study from Blood Advances . The study consists of 2,813 patients from the Center for International Blood and Marrow Transplant Research registry who underwent T-cell replete HCT for acute myeloid leukemia, acute lymphoblastic leukemia or myelodysplastic syndrome. Researchers discovered ...
0 comments
Be the first person to recommend this.
As of May 16, CMS has issued a notification announcing the opening of a National Coverage Analysis (NCA) for CAR-T.  The process officially opened on  May 16  and is estimated to conclude in  May 2019.   When an NCA is opened, it ends with a National Coverage Determination, which is then a binding, national coverage policy from which the regional contractors (MACs) are not able to deviate.   The triggering request for this process was made by United HealthCare and the request letter has been posted  here  .  Key Dates: Formal Request Accepted and Review Initiated:   05/16/2018 Public Comment Period:   05/16/2018 - 06/15/2018 ...
0 comments
Be the first person to recommend this.
May 2018 Download the full issue in PDF format here .  May 2018: A Message from the President It’s May, and spring is finally here (though this weather could have come a little sooner). Winters in the Midwest are often about staying inside — hibernating a bit, if you will — to recuperate for the better weather to come, which then fills this time of year with more energy and excitement. I, for one, am certainly excited about everything ASBMT has planned for the coming year. May 2018: Policy Perspective When I am crunched for time, I make lists. As the Centers for Medicare and Medicaid Services (CMS) Inpatient Prospective Payment System ...
0 comments
Be the first person to recommend this.
This article appeared in the May 2018 issue of ASBMT eNews. Download the full issue in PDF format here .  Immune effector cell therapy is a new, rapidly growing, and changing field. Educational initiatives are lagging as the field continues to evolve. The CAR-T (chimeric antigen receptor T-cell therapy) Working Group is an ongoing educational initiative to create a comprehensive resource library of CAR-T therapy developed by working group members. The working group members participate in two live meetings per year to review and discuss new research, trials, and areas of education to focus on; these updates are agreed upon by the working group and incorporated ...
0 comments
Be the first person to recommend this.
This article appeared in the May 2018 issue of ASBMT eNews. Download the full issue in PDF format here. On behalf of the ASBMT Committee on Education, we are pleased to continue our monthly self-directed learning quiz "Basic Principles and Practices of Hematopoietic Cell Transplantation and Cell Therapy – Question and Answer Approach” for fellows in training, highlighting HCT and cell therapy topics. Answers to each question appear with evidence-based “non-exhaustive” peer-review commentary. Our aim is to provide you with a credible and freely available educational resource. Questions were generated and reviewed by Syed Abutalib, MD, Mark R. Litzow, MD, ...
0 comments
Be the first person to recommend this.
This article appeared in the May 2018 issue of ASBMT eNews. Download the full issue in PDF format here .  A new monthly series, ASBMT's "Meet the Team" section will introduce you to the people who run the day-to-day operations of ASBMT. If you have any questions or need to reach out to someone on the team, please don't hesitate to reach out ; we love hearing from and helping members!  Kelsey Redman, ASBMT Operations Associate Kelsey Redman works on our operations team and is likely the first person you’ll speak to when calling the ASBMT main office. Her role focuses on membership support, helping members navigate the website, answering questions via ...
0 comments
Be the first person to recommend this.
This article appeared in the May 2018 issue of ASBMT eNews. Download the full issue in PDF format here .  Register today for the 4 th International Workshop on Biology, Prevention and Treatment of Relapse after HSCT . Relapse and disease progression are the leading causes of treatment failure for most hematologic malignancies treated with both allogeneic and autologous hematopoietic stem cell transplantation (HSCT). The planned objectives of the workshop are designed to present the latest scientific and clinical advances related to relapse after HSCT and to provide a forum for the presentation of ongoing laboratory, translational and clinical research specifically ...
0 comments
Be the first person to recommend this.
This article is part of the May 2018 issue of ASBMT eNews. View the full issue in PDF format here .  A Word from ASBMT President, John F. DiPersio, M.D., Ph.D. It’s May, and spring is finally here (though this weather could have come a little sooner). Winters in the Midwest are often about staying inside — hibernating a bit, if you will — to recuperate for the better weather to come, which then fills this time of year with more energy and excitement. I, for one, am certainly excited about everything ASBMT has planned for the coming year. In late April, I met with the ASBMT leadership team and the CIBMTR team to discuss the 2019 Transplantation and Cellular ...
0 comments